{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:07:28Z","timestamp":1794492448060,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PP00P1-123516\/1"],"award-info":[{"award-number":["PP00P1-123516\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PP00P1-146326\/1"],"award-info":[{"award-number":["PP00P1-146326\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.euroneuro.2017.08.425","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T02:31:15Z","timestamp":1504233075000},"page":"987-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Discrete memory impairments in largely pure chronic users of MDMA"],"prefix":"10.1016","volume":"27","author":[{"given":"Michael D.","family":"Wunderli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Vonmoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sch\u00e4delin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus R.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris B.","family":"Quednow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2017.08.425_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1076\/clin.17.4.446.27939","article-title":"Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users","volume":"17","author":"Back-Madruga","year":"2003","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1212\/WNL.51.6.1532","article-title":"Memory impairment in abstinent MDMA (\"Ecstasy\") users","volume":"51","author":"Bolla","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2005.03.002","article-title":"MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats","volume":"49","author":"Clemens","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib5","series-title":"Statistical Power Analysis for The Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/02791072.2014.878148","article-title":"MDMA and the \"ecstasy paradigm\"","volume":"46","author":"Cole","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(25)00317-9","article-title":"Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain","volume":"241","author":"Commins","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.forsciint.2011.10.024","article-title":"Society of Hair Testing guidelines for drug testing in hair","volume":"218","author":"Cooper","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002130000591","article-title":"The relative contributions of ecstasy and cannabis to cognitive impairment","volume":"153","author":"Croft","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/107319110000700202","article-title":"Does the letter number sequencing task measure anything more than digit span?","volume":"7","author":"Crowe","year":"2000","journal-title":"Assessment"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000026668","article-title":"Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research","volume":"42","author":"Curran","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881108089815","article-title":"Evidence for selective executive function deficits in ecstasy\/polydrug users","volume":"23","author":"Fisk","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1348\/0007126042369785","article-title":"Evidence for executive deficits among users of MDMA (Ecstasy)","volume":"95","author":"Fisk","year":"2004","journal-title":"Br. J. Psychol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/13803390490510680","article-title":"Age-related impairment in executive functioning: updating, inhibition, shifting, and access","volume":"26","author":"Fisk","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-002-1071-9","article-title":"Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (\"ecstasy\") polydrug users","volume":"162","author":"Fox","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hup.344","article-title":"Auditory verbal learning in drug-free ecstasy polydrug users","volume":"16","author":"Fox","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.neuropsychologia.2004.04.002","article-title":"Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex","volume":"42","author":"Goldstein","year":"2004","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.68.6.719","article-title":"Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)","volume":"68","author":"Gouzoulis-Mayfrank","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0278-5846(03)00114-3","article-title":"Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users","volume":"27","author":"Gouzoulis-Mayfrank","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib21","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","article-title":"Altered serotonin innervation patterns in the forebrain of monkeys treated with (+\/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery","volume":"19","author":"Hatzidimitriou","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib22","unstructured":"Helmstaedter, C., Lendt, M., Lux, S., 2001. Verbaler Lern- und Merkf\u00e4higkeitstest. Beltz, G\u00f6ttingen."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0091-3057(91)90106-C","article-title":"Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue","volume":"40","author":"Johnson","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0028-3908(91)90192-E","article-title":"Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in rats","volume":"30","author":"Johnson","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13803390490515694","article-title":"Neurocognitive deficits in cocaine users: a quantitative review of the evidence","volume":"27","author":"Jovanovski","year":"2005","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib26","first-page":"917","article-title":"The pharmacology and toxicology of \"ecstasy\" (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-006-0601-2","article-title":"MDMA use and neurocognition: a meta-analytic review","volume":"189","author":"Kalechstein","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hup.857","article-title":"Ecstasy (MDMA) and memory function: a meta-analytic update","volume":"22","author":"Laws","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0404.1995.tb07018.x","article-title":"Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence","volume":"91","author":"Lehrl","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pbb.2005.02.017","article-title":"Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions","volume":"81","author":"Lundqvist","year":"2005","journal-title":"Pharmacol. Biochem Behav."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s002130050967","article-title":"Cognitive performance in (+\/-) 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\") users: a controlled study","volume":"143","author":"McCann","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1017\/S1355617705050915","article-title":"Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective","volume":"11","author":"Medina","year":"2005","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/cogp.1999.0734","article-title":"The unity and diversity of executive functions and their contributions to complex \"Frontal Lobe\" tasks: a latent variable analysis","volume":"41","author":"Miyake","year":"2000","journal-title":"Cogn. Psychol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00213-005-0065-9","article-title":"The differential effects of ecstasy\/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory","volume":"182","author":"Montgomery","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s002130050803","article-title":"Memory deficits associated with recreational use of \"ecstasy\" (MDMA)","volume":"141","author":"Morgan","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp.51.6.757","article-title":"Planning and spatial working memory in Parkinson's disease","volume":"51","author":"Morris","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/00952990701764821","article-title":"Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence","volume":"34","author":"Pace-Schott","year":"2008","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hup.351","article-title":"Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research","volume":"16","author":"Parrott","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-3057(01)00711-0","article-title":"Recreational Ecstasy\/MDMA, the serotonin syndrome, and serotonergic neurotoxicity","volume":"71","author":"Parrott","year":"2002","journal-title":"Pharmacol. Biochem Behav."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00213-003-1712-7","article-title":"Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity","volume":"173","author":"Parrott","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hup.2318","article-title":"Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research","volume":"28","author":"Parrott","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib42","series-title":"Neuropathology of Drug Addictions and Substance Misuse","first-page":"257","article-title":"The rise of the ego: social cognition and interaction in cocaine users","author":"Quednow","year":"2016"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0269881106061200","article-title":"Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction","volume":"20","author":"Quednow","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.npp.1300396","article-title":"Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls","volume":"29","author":"Quednow","year":"2004","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00213-005-0256-4","article-title":"Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (\"Ecstasy\")","volume":"189","author":"Quednow","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s002130050057","article-title":"Memory disturbances in \"Ecstasy\" users are correlated with an altered brain serotonin neurotransmission","volume":"148","author":"Reneman","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(88)91309-1","article-title":"Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration","volume":"446","author":"Ricaurte","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib48","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1017\/S0033291716000258","article-title":"Meta-analysis of executive functioning in ecstasy\/polydrug users","volume":"46","author":"Roberts","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neubiorev.2016.02.003","article-title":"Meta-analysis of molecular imaging of serotonin transporters in ecstasy\/polydrug users","volume":"63","author":"Roberts","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130000467","article-title":"Cognitive performance amongst recreational users of \"ecstasy\"","volume":"151","author":"Rodgers","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13060","article-title":"The harmful health effects of recreational ecstasy: a systematic review of observational evidence","volume":"13","author":"Rogers","year":"2009","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib52","first-page":"888","article-title":"Tools for the diagnosis of attention-deficit\/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist","volume":"75","author":"Rosler","year":"2004","journal-title":"Der Nervenarzt"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib53","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1073\/pnas.89.5.1817","article-title":"The molecular mechanism of \"ecstasy\" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release","volume":"89","author":"Rudnick","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(98)00051-9","article-title":"MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients","volume":"52","author":"Schifano","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(91)90788-R","article-title":"L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats","volume":"203","author":"Schmidt","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: a critical review and meta-analysis","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib57","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1046\/j.1360-0443.2002.00213.x","article-title":"The impact of regular ecstasy use on memory function","volume":"97","author":"Simon","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib58","series-title":"A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary","author":"Strauss","year":"2006"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-002-1383-9","article-title":"Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users","volume":"167","author":"Thomasius","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269881106059486","article-title":"Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective","volume":"20","author":"Thomasius","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4236\/jbbs.2012.21013","article-title":"Clinical validation of Cambridge neuropsychological test automated battery in a Norwegian epilepsy population","volume":"2","author":"Torgersen","year":"2012","journal-title":"J. Behav. Brain Sci."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib62","series-title":"World Drug Report 2016","author":"United Nations Office on Drugs and Crime","year":"2016"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addbeh.2004.04.015","article-title":"Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis","volume":"30","author":"Verdejo-Garcia","year":"2005","journal-title":"Addict. Behav."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1192\/bjp.bp.112.118091","article-title":"Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset","volume":"203","author":"Vonmoos","year":"2013","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib65","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/npp.2014.71","article-title":"Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study","volume":"39","author":"Vonmoos","year":"2014","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fnins.2015.00445","article-title":"Learning, Memory, and Executive Function in New MDMA Users: a 2-Year Follow-Up Study","volume":"9","author":"Wagner","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib67","article-title":"Wechsler memory scale (WMS-III)","author":"Wechsler","year":"1997","journal-title":"Psychol. Corp"},{"key":"10.1016\/j.euroneuro.2017.08.425_bib68","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/npp.2008.60","article-title":"The neuropsychology of cocaine addiction: recent cocaine use masks impairment","volume":"34","author":"Woicik","year":"2009","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.08.425_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2016.03.026","article-title":"Cognitive and emotional impairments in adults with attention-deficit\/hyperactivity disorder and cocaine use","volume":"163","author":"Wunderli","year":"2016","journal-title":"Drug Alcohol Depend."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17308921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17308921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:51:19Z","timestamp":1760377879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X17308921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0924977X17308921"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.08.425","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrete memory impairments in largely pure chronic users of MDMA","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.08.425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}